U-PLOID BIOTECHNOLOGIES LTD

15432020
Active Oxford

Research and experimental development on biotechnology

6 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
U

U-PLOID BIOTECHNOLOGIES LTD

15432020

Research and experimental development on biotechnology

Founded 22 Jan 2024 Active Oxford, England 6 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 28 Apr 2026 Next due 31 Oct 2026 4 months remaining
Confirmation Submitted 1 Aug 2025 Next due 15 Aug 2026 1 month remaining
Net assets £716K £131K 2025 year on year
Total assets £734K £140K 2025 year on year
Total Liabilities £18K £9K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Building 696, Innovation Building, Bioescalator Old Road Campus, Roosevelt Drive Headington Oxford OX3 7FZ England

Email

info@example.com

Website

www.example.com

Full company profile for U-PLOID BIOTECHNOLOGIES LTD (15432020), an active life sciences and medical technology company based in Oxford, England. Incorporated 22 Jan 2024. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Feb → 31 Jan 2026
Type total-exemption-full
Next accounts 31 Jan 2026
Due by 31 Oct 2026 4 months remaining

Net Assets, Total Assets & Total Liabilities (2024–2025)

Cash in Bank

£585.27k

Decreased by £116.89k (-17%)

Net Assets

£716.26k

Decreased by £131.02k (-15%)

Total Liabilities

£18.01k

Decreased by £8.97k (-33%)

Turnover

N/A

Employees

6

Increased by 3 (+100%)

Debt Ratio

2%

Decreased by 1 (-33%)

Financial History

Revenue, profit, EBITDA and key financial figures

2026
31 Jan Year End
2025
31 Jan Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

2 Allotments 1,542,538 Shares £120k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
21 Nov 202542,538£120k£2.818
18 Jul 20241,500,000£1.5£0

Officers

Officers

3 active
Status
Chloe Amelia CharalambousDirectorBritishEngland3118 Jul 2024Active
Jeremy James Anthony BuzzardDirectorAustralian,americanUnited States4825 Sept 2024Active
Jordan AbdiDirectorBritishEngland3218 Jul 2024Active

Shareholders

Shareholders (4)

Alexandre Webster
40.0%
Chloe Amelia Charalambous
35.0%

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Alexandre Webster

British,american

Active
Notified 22 Jan 2024
Residence United Kingdom
DOB December 1985
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Chloe Amelia Charalambous

British

Active
Notified 23 Jul 2024
Residence England
DOB December 1994
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
28 Apr 2026AccountsAnnual accounts made up to 31 Jan 2026
28 Apr 2026ResolutionResolutions
21 Nov 2025CapitalAllotment of shares (GBP 2.542538) on 21 Nov 2025
4 Aug 2025OfficersChange to director Dr Chloe Amelia Charalambous on 1 Aug 2025
1 Aug 2025Confirmation StatementConfirmation statement made on 1 Aug 2025 with no updates
28 Apr 2026 Accounts

Annual accounts made up to 31 Jan 2026

28 Apr 2026 Resolution

Resolutions

21 Nov 2025 Capital

Allotment of shares (GBP 2.542538) on 21 Nov 2025

4 Aug 2025 Officers

Change to director Dr Chloe Amelia Charalambous on 1 Aug 2025

1 Aug 2025 Confirmation Statement

Confirmation statement made on 1 Aug 2025 with no updates

Recent Activity

Latest Activity

Annual accounts made up to 31 Jan 2026

1 months ago on 28 Apr 2026

Resolutions

1 months ago on 28 Apr 2026

Allotment of shares (GBP 2.542538) on 21 Nov 2025

7 months ago on 21 Nov 2025

Change to director Dr Chloe Amelia Charalambous on 1 Aug 2025

10 months ago on 4 Aug 2025

Confirmation statement made on 1 Aug 2025 with no updates

10 months ago on 1 Aug 2025